Have a feature idea you'd love to see implemented?
Let us know!
PIII P3 Health Partners Inc
Price (delayed)
$0.227
Market cap
$81.45M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.78
Enterprise value
$157.95M
Highlights
The revenue is up by 25% year-on-year and by 5% since the previous quarter
The EPS has soared by 71% year-on-year but it has declined by 28% since the previous quarter
P3 Health Partners's net income has decreased by 48% from the previous quarter but it has increased by 19% YoY
The gross margin has plunged by 182% YoY
PIII's equity is down by 36% YoY and by 28% from the previous quarter
Key stats
What are the main financial stats of PIII
Market
Valuations
Earnings
Shares outstanding
358.82M
Market cap
$81.45M
Enterprise value
$157.95M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.67
Price to sales (P/S)
0.02
EV/EBIT
N/A
EV/EBITDA
35.64
EV/Sales
0.11
Revenue
$1.48B
Gross profit
-$52.62M
Net income
-$102.69M
EBIT
-$82.11M
EBITDA
$4.43M
Free cash flow
-$68.56M
Per share
Balance sheet
Liquidity
EPS
-$0.78
EPS diluted
-$0.84
Free cash flow per share
-$0.42
Book value per share
$0.34
Revenue per share
$9.12
TBVPS
$1.47
Total assets
$833.33M
Total liabilities
$569.42M
Debt
$144.59M
Equity
$120.51M
Working capital
-$190.25M
Debt to equity
1.2
Current ratio
0.53
Quick ratio
0.48
Net debt/EBITDA
17.26
Margins
Efficiency
Dividend
EBITDA margin
0.3%
Gross margin
-3.6%
Net margin
-7%
Operating margin
-16.7%
Return on assets
-11.9%
Return on equity
-71.3%
Return on invested capital
N/A
Return on capital employed
-19.2%
Return on sales
-5.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
PIII stock price
How has the P3 Health Partners stock price performed over time
Intraday
5.63%
1 week
-6.31%
1 month
10.73%
1 year
-82.67%
YTD
0.93%
QTD
0.93%
Financial performance
How have P3 Health Partners's revenue and profit performed over time
Revenue
$1.48B
Gross profit
-$52.62M
Operating income
-$246.42M
Net income
-$102.69M
Gross margin
-3.6%
Net margin
-7%
The gross margin has plunged by 182% YoY
The company's operating margin has surged by 69% YoY but it fell by 36% QoQ
P3 Health Partners's operating income has surged by 62% YoY but it has decreased by 42% QoQ
P3 Health Partners's net income has decreased by 48% from the previous quarter but it has increased by 19% YoY
Growth
What is P3 Health Partners's growth rate over time
Valuation
What is P3 Health Partners stock price valuation
P/E
N/A
P/B
0.67
P/S
0.02
EV/EBIT
N/A
EV/EBITDA
35.64
EV/Sales
0.11
The EPS has soared by 71% year-on-year but it has declined by 28% since the previous quarter
PIII's P/B is 63% below its last 4 quarters average of 1.8
PIII's equity is down by 36% YoY and by 28% from the previous quarter
PIII's price to sales (P/S) is 80% lower than its last 4 quarters average of 0.1
The revenue is up by 25% year-on-year and by 5% since the previous quarter
Efficiency
How efficient is P3 Health Partners business performance
PIII's return on equity has surged by 92% year-on-year but it has dropped by 65% since the previous quarter
The ROS has dropped by 70% since the previous quarter but it is up by 39% year-on-year
P3 Health Partners's ROA has plunged by 51% from the previous quarter but it has increased by 16% YoY
Dividends
What is PIII's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for PIII.
Financial health
How did P3 Health Partners financials performed over time
P3 Health Partners's total assets is 46% more than its total liabilities
The company's total liabilities rose by 44% YoY and by 8% QoQ
The quick ratio has contracted by 27% from the previous quarter and by 27% YoY
PIII's debt is 20% higher than its equity
P3 Health Partners's debt to equity has soared by 85% YoY and by 36% from the previous quarter
PIII's equity is down by 36% YoY and by 28% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.